INT338102

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.07
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

lyase activity (CA4) Golgi apparatus (CA4)
Anatomy Link Frequency
blood vessels 1
CA4 (Homo sapiens)
Pain Link Frequency Relevance Heat
COX-2 inhibitor 1 44.20 Quite Low
COX2 1 41.92 Quite Low
withdrawal 8 5.00 Very Low Very Low Very Low
imagery 4 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Neuropeptide 1 5.00 Very Low Very Low Very Low
Catecholamine 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 57 96.20 Very High Very High Very High
Thyroid Neoplasm 169 94.80 High High
Disease 81 81.52 Quite High
Malignant Neoplastic Disease 11 58.12 Quite High
Hypertension 1 19.80 Low Low
Diarrhoea 3 19.12 Low Low
Toxicity 2 9.72 Low Low
Disease Progression 1 8.72 Low Low
Metastasis 37 5.00 Very Low Very Low Very Low
Carcinoma 27 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Unlike the other angiogenesis inhibitors such as bevacizumab, an antibody against VEGF, or the VEGF receptor kinase inhibitors, CA4P is a tubulin-binding vascular disrupting agent that stops blood flow through existing blood vessels, depriving the tumor of its nutrients and oxygen.
CA4P Binding (binding) of in blood vessels associated with cancer
1) Confidence 0.01 Published 2010 Journal Journal of Thyroid Research Section Body Doc Link PMC2956973 Disease Relevance 1.07 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox